Treatment Switching Patterns between Gaviscon Formulations and Other Alginates Prescribed for Gastroesophageal Reflux Disease (GERD) In Routine, General Practice

Williams D, Currie C J, Okhuoya P, Wilkinson J M and Berni E R. 17 Aug 2016


Resource Use Associated With Hepatic Encephalopathy In Patients With Severe Liver Disease

Orr J, Morgan C L, Hudson M, Jenkins-Jones S, Conway P, Radwan A, Currie C J. 09 Jun 2014


Cost Effectiveness Of Rifaximin-α In The Reduction Of Recurrence Of Overt Hepatic Encephalopathy

Poole C D, Conway P, Nanuwa K, Joseph B, Bannister Ch A, and Currie C J. 09 Jun 2014


The First Evaluation Of The Relationship Between The Chronic Liver Disease Questionnaire And The Eq-5d Index In Hepatic Encephalopathy Patients Treated With Rifaximin-α

E Berni, C Bannister, CD Poole, P Conway, K Nanuwa, CJ Currie. 09 Jun 2014

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services